NCT07543393Not yet recruiting
Nudging for Anticoagulation Adherence in Atrial Fibrillation
The Effects of Nudging Intervention in Promoting Adherence to Anticoagulation Among Patients With Atrial Fibrillation: a Randomized Controlled Trail
Source: ClinicalTrials.gov · Last updated 26 Jun 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if a nudging intervention (using text message reminders, a medication calendar, and action planning) can help people with atrial fibrillation take their blood-thinning medication (anticoagulants) as prescribed. The main questions it aims to answer are: Does the nudging intervention improve medication adherence compared to usual care? How does the intervention affect patients' beliefs about their medication and the automaticity of pill-taking? Is the intervention cost-effective? Researchers will compare participants who receive the nudging intervention with those who receive usual care. Participants will: Watch a short educational video about atrial fibrillation and stroke prevention Make a personal plan to take their medication at the same time each day (for example, after breakfast) Receive text message reminders 1 to 3 times per week, with fewer messages over time Get a medication calendar to track daily doses Answer a few questionnaires at the start, at 8 weeks, and at 12 weeks
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- First submitted
- 14 Apr 2026
- Start date
- 30 Jun 2026
- Primary completion date
- 20 Feb 2027
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Atrial fibrillation
- NCT number
- NCT07543393
What you commit to
- Study type: Interventional
- Planned participants: 84
- From 30 Jun 2026 to the primary completion date, 20 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment or psychiatric disorder that would preclude completion of questionnaires or adherence to the intervention
- Life expectancy \<6 months due to comorbid conditions
- Currently enrolled in another medication adherence intervention study
- Unable to read or understand Chinese (since validated Chinese scales are used)
Who the study is looking for
- Age ≥18 years
- Diagnosed with non-valvular atrial fibrillation (AF) confirmed by medical records
- Prescribed oral anticoagulants (e.g., warfarin, rivaroxaban, apixaban, dabigatran, edoxaban) for at least 3 months
- Own a personal mobile phone capable of receiving SMS messages
- Willing and able to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University Coordinator of this site? Confirm its status | Gu'ang'zhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.